Aducanumab: A Deep Dive into BIIB037 and its Impact The medication, originally known as BIIB037, is a significant endeavor to address emerging Alzheimer's illness. Designed by Biogen, the treatment works by removing https://www.targetmol.com/compound/aducanumab